measuregroup/AID1805117

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442076397_AID1805117_PMID_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442076396_AID1805117_PMID_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442076397_AID1805117_PMID_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442076396_AID1805117_PMID_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442076397_AID1805117_PMID_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442076396_AID1805117_PMID_VALUE2
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ01959 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31645 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23975
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	Radioligand Binding Assays from US Patent US10875829: \"Azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442076397 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442076396
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1805117

Total number of triples: 15.